Covered recipient · General Payments record
ELIO R NOVOA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$2,249.12
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.20 | 19 |
| Consulting Fee | $11.41 | 4 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.24 | 9 |
| Novo Nordisk AS | $44.59 | 3 |
| Amarin Pharma Inc. | $37.52 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.86 | 1 |
| PFIZER INC. | $17.67 | 1 |
| Abbott Laboratories | $16.78 | 1 |
| Horizon Pharma plc | $13.29 | 1 |
| Esperion Therapeutics, Inc. | $12.25 | 1 |
| KVK-Tech, Inc. | $11.41 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2021 201820192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.78 | 06/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815581371 | CMS |
| AbbVie Inc. | $29.39 | 01/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380843 | CMS |
| AbbVie Inc. | $19.53 | 02/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380849 | CMS |
| AbbVie Inc. | $27.74 | 02/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380855 | CMS |
| AbbVie Inc. | $10.86 | 04/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380861 | CMS |
| AbbVie Inc. | $10.81 | 05/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380867 | CMS |
| AbbVie Inc. | $13.40 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380873 | CMS |
| AbbVie Inc. | $26.57 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380879 | CMS |
| AbbVie Inc. | $27.29 | 07/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380885 | CMS |
| AbbVie Inc. | $26.65 | 07/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795380891 | CMS |
| Amarin Pharma Inc. | $12.81 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815414943 | CMS |
| Amarin Pharma Inc. | $24.71 | 06/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815303375 | CMS |
| Esperion Therapeutics, Inc. | $12.25 | 05/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838363567 | CMS |
| Horizon Therapeutics plc | $13.29 | 07/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 797180177 | CMS |
| KVK-Tech, Inc. | $3.40 | 01/14/2021 | Consulting Fee | Undisputed | 01/23/2026 | 773456406 | CMS |
| KVK-Tech, Inc. | $3.03 | 03/04/2021 | Consulting Fee | Undisputed | 01/23/2026 | 773456408 | CMS |
| KVK-Tech, Inc. | $2.09 | 11/11/2021 | Consulting Fee | Undisputed | 01/23/2026 | 773457042 | CMS |
| KVK-Tech, Inc. | $2.89 | 12/13/2021 | Consulting Fee | Undisputed | 01/23/2026 | 773457074 | CMS |
| Novo Nordisk Inc | $13.58 | 03/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810664523 | CMS |
| Novo Nordisk Inc | $15.10 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810664526 | CMS |
| Novo Nordisk Inc | $15.91 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810802203 | CMS |
| PFIZER INC. | $17.67 | 06/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833410087 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.86 | 06/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820115411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.